Capital Flow Monitor · Sponsors · CIK 1827388
Orion Biotechnology Canada Ltd.
343 PRESTON STREET, 11TH FLOOR, OTTAWA, ONTARIO, Z4, K1S1N4 · 3432911032
Biotechnology · Corporation· inc. CANADA (FEDERAL LEVEL) true
Fit score
—
Offering
$15.0M
Sold
$6.8M
% sold
45.4%
Investors
34
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-08-26 | D/A ·current | 506(b) | $15.0M | $6.8M | 45.4% | 34 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Mark Groper — Director, Ottawa, Ontario, Z4
-
Praveen Tyle — Executive Officer / Director, Ottawa, Ontario, Z4
1 other raise
- KIORA PHARMACEUTICALS INC $5.0M of $5.0M · 100.0%
- Jean Forcione — Director, Ottawa, Ontario, Z4
- John Jussup — Executive Officer, Ottawa, Ontario, Z4
- Anatolii Klepatsky — Executive Officer / Director, Ottawa, Ontario, Z4
- Bradford Smith — Director, Ottawa, Ontario, Z4
- Lonnel Coats — Director, Ottawa, A6
- Katie Hewitt — Director, Ottawa, A6
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.